Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kranse

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Prostate|January 5, 2000
Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?F H Schröder, R Kranse, N Barbet, et al.
International Journal of Cancer|July 15, 1999
Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)P M Beemsterboer, R Kranse, H J de Koning, et al.
British Journal of Urology|April 1, 1997
Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detectionJ B Rietbergen, R Kranse, W J Kirkels, et al.
Urology|February 13, 2001
Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examinationF H Schröder, M Roobol-Bouts, A N Vis, et al.
BJU International|March 2, 2002
Serendipity in detecting disease in low prostate-specific antigen rangesA N Vis, R Kranse, M Roobol, et al.
World Journal of Urology|January 1, 1997
Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate CancerR F Hoedemaeker, J B Rietbergen, R Kranse, et al.
The Journal of Urology|June 1, 1997
The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general populationC H Bangma, J B Rietbergen, R Kranse, et al.
The Journal of Urology|July 14, 2000
Histopathological prostate cancer characteristics at radical prostatectomy after population based screeningR F Hoedemaeker, J B Rietbergen, R Kranse, et al.
Urologia Internationalis|March 31, 1998
Microvascular invasion in prostate cancer: prognostic significance in patients treated by radical prostatectomy for clinically localized carcinomaD van den Ouden, R Kranse, W C Hop, et al.
Journal of the National Cancer Institute|December 5, 1998
Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate CancerF H Schröder, P van der Maas, P Beemsterboer, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Prostate|January 5, 2000
Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?F H Schröder, R Kranse, N Barbet, et al.
International Journal of Cancer|July 15, 1999
Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)P M Beemsterboer, R Kranse, H J de Koning, et al.
British Journal of Urology|April 1, 1997
Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detectionJ B Rietbergen, R Kranse, W J Kirkels, et al.
Urology|February 13, 2001
Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examinationF H Schröder, M Roobol-Bouts, A N Vis, et al.
BJU International|March 2, 2002
Serendipity in detecting disease in low prostate-specific antigen rangesA N Vis, R Kranse, M Roobol, et al.
World Journal of Urology|January 1, 1997
Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate CancerR F Hoedemaeker, J B Rietbergen, R Kranse, et al.
The Journal of Urology|June 1, 1997
The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general populationC H Bangma, J B Rietbergen, R Kranse, et al.
The Journal of Urology|July 14, 2000
Histopathological prostate cancer characteristics at radical prostatectomy after population based screeningR F Hoedemaeker, J B Rietbergen, R Kranse, et al.
Urologia Internationalis|March 31, 1998
Microvascular invasion in prostate cancer: prognostic significance in patients treated by radical prostatectomy for clinically localized carcinomaD van den Ouden, R Kranse, W C Hop, et al.
Journal of the National Cancer Institute|December 5, 1998
Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate CancerF H Schröder, P van der Maas, P Beemsterboer, et al.
Pageof 4